用胰岛素调节肠道微生物群改善了多囊性卵巢综合征患者的新陈代谢和卵巢功能
Lulu Geng1, Xin Yang2,3, Jiani Sun1
1Centre for Assisted Reproduction, Shanghai Key Laboratory of Maternal-Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|April 7, 2025
概括
胰岛素通过调节肠道微生物群,增强新陈代谢和减少炎症来改善多囊性卵巢综合征 (PCOS). 这项研究强调了微生物群调节作为PCOS代谢障碍的有前途的治疗策略.
科学领域:
- 内分泌学 在内分泌学.
- 微生物学 微生物学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 多囊卵巢综合征 (PCOS) 与代谢功能障碍和肠道微生物群失调有关.
- 肠道微生物群影响PCOS的确切机制尚不清楚.
研究的目的:
- 调查肠道微生物群调节剂胰岛素在缓解PCOS相关代谢障碍中的作用.
- 阐明涉及肠道微生物群的潜在机制.
主要方法:
- 在PCOS患者和小鼠模型中的胰岛素治疗.
- 对肠道微生物群组成,短链脂肪酸 (SCFA) 生产和炎症标志物的分析.
- 脂聚糖 (LPS) 挑战和便微生物群移植 (FMT) 实验.
主要成果:
- 胰岛素在PCOS队列和小鼠中改善了高雄激素和葡萄糖脂代谢.
- 胰岛素增加了有益的肠道细菌 (例如Bifidobacterium) 和SCFA的产生.
- 胰岛素降低了炎症标志物 (LBP) 和卵巢炎症,其影响被LPS扭转.
结论:
- 肠道微生物群调解了胰岛素对PCOS代谢障碍和卵巢功能障碍的有益作用.
- 通过像胰岛素这样的药物调节肠道微生物群是PCOS的潜在治疗策略.
相关概念视频
Oogenesis
63.2K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.2K
Irritable Bowel Syndrome I: Introduction
209
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
209
Irritable Bowel Syndrome III: Medical and Nursing Management
123
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
123
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
253
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
253
Hormonal Regulation
43.0K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.0K
Drugs for Treatment of Constipation-Predominant IBS
117
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
117


